Physician profile
Aaron L Bey
NPI 1801053483
$13,467.02
in general payments reported to CMS, 2019-2025
49 companies · $2,779 in 2025
The $2,779 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,916 · 2020: $1,155 · 2021: $1,588 · 2022: $1,516 · 2023: $1,886 · 2024: $2,627 · 2025: $2,779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,157 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125 · Education: $10.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,156.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $125.00 |
| Education | $10.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,449.34 | 2019-2020 | |
| Teleflex LLC | $1,420.73 | 2021-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $921.26 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $859.98 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $808.42 | 2019-2025 | Myrbetriq, Xtandi |
| Dendreon Pharmaceuticals LLC | $653.18 | 2019-2025 | Provenge |
| Urogen Pharma, INC. | $634.35 | 2020-2025 | Jelmyto |
| Procept Biorobotics Corporation | $617.08 | 2019-2024 | Aquabeam Robotic System, Aquabeam System |
| Boston Scientific Corporation | $536.06 | 2023-2025 | Ams 700, Lithovue, Lithoclast |
| Axonics, INC. | $533.81 | 2020-2024 | Axonics |
| Calyxo, INC. | $441.34 | 2022-2025 | Cvac Aspiration System |
| Abbvie INC. | $390.15 | 2019-2024 | Botox |
| Merck Sharp & Dohme LLC | $385.18 | 2022-2025 | Lynparza, Keytruda, Welireg |
| Ferring Pharmaceuticals INC. | $339.52 | 2020-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $332.47 | 2019-2025 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $332.20 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Pfizer INC. | $259.77 | 2019-2025 | |
| Srs Medical Systems, INC. | $253.58 | 2024-2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Myovant Sciences INC. | $239.21 | 2021-2022 | |
| Olympus America INC. | $235.37 | 2023-2025 | Itind System |
| Immunitybio, INC. | $224.11 | 2024-2025 | |
| Coloplast Corp | $152.69 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $143.93 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Medtronic, INC. | $141.21 | 2025 | Interstim |
| Blue Earth Diagnostics | $125.07 | 2020-2022 | |
| Urovant Sciences INC | $115.38 | 2021-2022 | |
| Accord Healthcare, INC. | $100.75 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $100.16 | 2020-2021 | |
| Tolmar Pharmaceuticals, INC. | $87.31 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $80.40 | 2021-2025 | |
| Acerus Pharmaceuticals Corporation | $77.53 | 2020-2021 | |
| Progenics Pharmaceuticals, INC. | $71.25 | 2023-2024 | Pylarify |
| Allergan, INC. | $68.51 | 2021-2022 | |
| Tolmar, INC. | $47.70 | 2024 | |
| Clarus Therapeutics INC. | $41.59 | 2021 | |
| Karl Storz Endoscopy-America | $30.15 | 2025 | |
| Becton, Dickinson and Company | $29.10 | 2024 | Arista Ah Flexitip |
| Astrazeneca Pharmaceuticals LP | $28.35 | 2020 | |
| Endo USA, INC. | $21.73 | 2024 | Xiaflex |
| Verity Pharmaceuticals INC. | $19.24 | 2025 | Tlando |
| Angiodynamics, INC. | $18.84 | 2024 | Nanoknife |
| Alnylam Pharmaceuticals INC. | $15.66 | 2021 | |
| Bard Peripheral Vascular, INC. | $14.29 | 2025 | Model 200 Theraseed Palladium-103 In Readylink |
| Conmed Corporation | $13.80 | 2020 | |
| Metuchen Pharmaceuticals | $13.36 | 2019 | |
| Mission Pharmacal Company | $12.78 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.26 | 2022 | |
| Hollister Incorporated | $11.31 | 2021 | |
| Travere Therapeutics, INC. | $5.56 | 2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Bey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.